« Previous
Next »
Gastroenterology
Volume 137, Issue 4
, Pages 1425-1434
, October 2009
Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome
References
- AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108–2131
- Review article: the psychoneuroimmunology of irritable bowel syndrome—an exploration of interactions between psychological, neurological and immunological observations. Aliment Pharmacol Ther. 2008;28:830–840
- Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007;19:62–88
- Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008;6:772–781
- . Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol. 2006;22:13–17
- . Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18:641–661
- . Is irritable bowel syndrome a low-grade inflammatory bowel disease?. Gastroenterol Clin North Am. 2005;34:235–245
- Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol. 2008;43:1467–1476
- Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006;101:1288–1294
- Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut. 2009;58:196–201
- Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132:26–37
- Role for protease activity in visceral pain in irritable bowel syndrome 1. J Clin Invest. 2007;117:636–647
- Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702
- Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007;56:203–209
- . Serotonergic modulation of visceral sensation: lower gut. Gut. 2002;51(Suppl 1):i81–i86
- Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors. Gastroenterology. 2005;128:1317–1326
- . The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397–414
- Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125:1651–1659
- Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005;3:349–357
- Trypsinogen IV, serotonin transporter transcript levels, and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil. 2008;20:900–907
- Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets. Eur J Pharmacol. 2008;585:361–374
- Functional bowel disorders and functional abdominal pain. Gut. 1999;45(Suppl 2):II43–II47
- . Multisite optical recording of excitability in the enteric nervous system. Neurogastroenterol Motil. 1999;11:393–402
- Human mast cell mediator cocktail excites neurons in human and guinea-pig enteric nervous system. Neurogastroenterol Motil. 2005;17:281–289
- Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J Physiol. 2007;583:731–742
- . 5-HT system in the gut: roles in the regulation of visceral sensitivity and motor functions. Eur Rev Med Pharmacol Sci. 2008;12(Suppl 1):63–67
- Elevated motility-related transmucosal potential difference in the upper small intestine in the irritable bowel syndrome. Neurogastroenterol Motil. 2007;19:812–820
- First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet. 2008;17:2967–2977
- Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008;6:194–205
- Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913–920
- . Clinical relevance of proteinase activated receptors (pars) in the gut. Gut. 2005;54:867–874
- Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J Physiol. 2003;547:531–542
- . Proteinase-activated receptor-2 mediates hyperresponsiveness in isolated guinea pig bronchi. Biochem Pharmacol. 2003;66:519–525
- . Protease-activated receptors: contribution to physiology and disease. Physiol Rev. 2004;84:579–621
- Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev. 2005;26:1–43
- Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology. 2002;122:1035–1047
- Stimulation of proteinase-activated receptor 2 excites jejunal afferent nerves in anaesthetized rats. J Physiol. 2003;552:589–601
- Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems. Naunyn Schmiedebergs Arch Pharmacol. 2008;377:377–392
- The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133:24–33
- Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut. 2008;57:591–599
- Contribution of the microflora to proteolysis in the human large intestine. J Appl Bacteriol. 1988;64:37–46
- . Studies on amine production in the human colon: enumeration of amine forming bacteria and physiological effects of carbohydrate and pH. Anaerobe. 1996;2:285–297
Conflicts of interest The authors disclose no conflicts.
Funding Supported by Deutsche Forschungsgemeinschaft DFG Sche-267/7-1 (to M.S.); European Union 7th Framework Programme (IPODD) (to M.S.); Italian Ministry of University and Research (COFIN Projects to G.B., R.D.G.), R.F.O. funds from the University of Bologna (to R.D.G., V.S., G.B.), and a grant from the “Fondazione Del Monte di Bologna e Ravenna” (Bologna, Italy; to R.D.G.).
PII: S0016-5085(09)01152-4
doi: 10.1053/j.gastro.2009.07.005
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 137, Issue 4
, Pages 1425-1434
, October 2009

